Key terms
About VKTX
Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest VKTX news
Today
3:05am ET
Buy Rating Affirmed for Viking Therapeutics Amid Promising Obesity Drug Trials and Strategic Market Positioning
Yesterday
6:25am ET
3 Best Stocks to Buy Now, 3/28/2024, According to Top Analysts
Mar 27
10:05pm ET
Stifel Nicolaus Remains a Buy on Viking Therapeutics (VKTX)
Mar 27
7:53am ET
Viking Therapeutics price target raised to $138 from $116 at Oppenheimer
Mar 26
3:25pm ET
Buy Rating Affirmed for Viking Therapeutics on Strong Clinical Outcomes and Promising Obesity Program
Mar 26
3:12pm ET
Viking Therapeutics price target raised to $138 from $116 at Oppenheimer
Mar 26
12:09pm ET
Viking Therapeutics price target raised to $125 from $100 at BTIG
Mar 26
10:55am ET
Buy Rating Affirmed for Viking Therapeutics on Strong Phase 1 Results of Weight Loss Candidate VK2735
Mar 26
7:22am ET
Viking Therapeutics Clarifies Regulatory Disclosure Status
Mar 16
7:45am ET
Buy Rating Affirmed for Viking Therapeutics: Promising NASH Treatments and Competitive Edge in Metabolic Disease Pipeline
Mar 15
7:17am ET
Approval of Madrigal’s Rezdiffra positive for Viking and MASH space, says Stifel
Mar 15
7:14am ET
Viking Therapeutics price target raised to $100 from $86 at BTIG
Mar 11
12:47am ET
Maintaining Buy on Viking Therapeutics: Overreaction to Competitor’s Data and Confidence in VK2735’s Market Potential
Mar 08
7:15am ET
Truist Financial Gives a Buy Rating to Viking Therapeutics (VKTX)
Mar 08
6:30am ET
Analysts Are Bullish on Top Healthcare Stocks: Lumos Pharma (LUMO), Arcturus Therapeutics (ARCT)
Mar 07
3:34pm ET
Novo results raising the bar for Viking’s oral VK2735, says Oppenheimer
Mar 07
4:52am ET
Viking Therapeutics initiated with a Buy at Jefferies
Mar 07
4:21am ET
Analysts Are Bullish on Top Healthcare Stocks: Viking Therapeutics (VKTX), Boston Scientific (BSX)
Mar 03
5:25am ET
BTIG Sticks to Its Buy Rating for Viking Therapeutics (VKTX)
Mar 01
11:04am ET
Biotech Alert: Searches spiking for these stocks today
Mar 01
9:40am ET
Unusually active option classes on open March 1st
Mar 01
7:31am ET
Viking Therapeutics price target raised to $120 from $38 at Truist
Feb 29
10:57am ET
Biotech Alert: Searches spiking for these stocks today
Feb 29
10:57am ET
Biotech Alert: Searches spiking for these stocks today
Feb 29
10:39am ET
Viking Therapeutics price target raised to $120 from $38 at Truist
Feb 29
9:40am ET
Unusually active option classes on open February 29th
Feb 28
9:04pm ET
Viking Therapeutics 6.47M share Secondary priced at $85.00
Feb 28
7:38am ET
Viking Therapeutics price target raised to $116 from $46 at Oppenheimer
Feb 27
3:33pm ET
Viking Therapeutics price target raised to $116 from $46 at Oppenheimer
Feb 27
2:56pm ET
Viking Therapeutics price target raised to $120 from $50 at Maxim
Feb 27
12:41pm ET
Viking Therapeutics price target raised to $115 from $37 at Raymond James
Today
9:15am ET
Is It Too Late to Buy Viking Therapeutics Stock?
Today
9:00am ET
Better Buy: Viking Therapeutics vs. Madrigal Pharmaceuticals
Today
8:51am ET
Why Viking Therapeutics Stock Was Rocketing Higher This Week
Yesterday
5:50am ET
5 Things You Need to Know If You Buy Viking Therapeutics Stock Today
Mar 26
11:28am ET
Why Viking Therapeutics Stock Is Skyrocketing Today
Mar 26
10:07am ET
Viking Therapeutics: Buy, Sell, or Hold?
Mar 26
5:51am ET
Best Obesity Drug Stock: Eli Lilly, Novo Nordisk, or Viking Therapeutics?
Mar 26
4:11am ET
2 Soaring Growth Stocks That Could Climb Another 47% to 73%, According to Wall Street
Mar 25
6:25am ET
Novo Nordisk and Eli Lilly May Finally Have Some Real Competition
Mar 24
9:15am ET
Is Viking Therapeutics Stock a Millionaire Maker?
Mar 23
5:53am ET
Where Will Viking Therapeutics Stock Be in 10 Years?
Mar 22
10:30am ET
With Shares Trading Near All-Time Highs, Is Now the Time to Take Profits in Novo Nordisk?
Mar 22
4:55am ET
Could Viking Therapeutics Become the Next Eli Lilly?
Mar 21
8:49am ET
Viking Therapeutics Stock Has 55% Upside, According to 1 Wall Street Analyst
Mar 20
8:30am ET
2 Incredible Growth Stocks to Buy Right Now
Mar 19
9:45am ET
Warning: This Skyrocketing Stock Has a Hidden Risk
Mar 17
9:15am ET
Where Will Viking Therapeutics Be in 5 Years?
Mar 17
5:50am ET
Madrigal Pharmaceuticals Wins Approval for the First Drug Targeting the Multibillion-Dollar NASH Market. Is the Stock a Screaming Buy?
Mar 16
8:17am ET
Will Viking Therapeutics Get Acquired?
Mar 15
9:45am ET
2 Stocks That Have More Than Tripled This Year: Are They Buys?
Mar 15
5:50am ET
Should Pfizer Acquire Viking Therapeutics to Take on Eli Lilly and Novo Nordisk in the Obesity Drug Market?
Mar 13
5:03am ET
Could Viking Therapeutics Challenge Giant Eli Lilly in the Billion-Dollar Weight-Loss Drug Market?
Mar 12
7:45am ET
1 Big New Reason to Buy Novo Nordisk Stock Hand Over Fist Right This Instant
Mar 11
6:53am ET
Is Viking Therapeutics Stock a Buy?
Mar 09
4:47pm ET
Missed Out on Eli Lilly and Novo Nordisk? This Could Be the Next Big Weight Loss Stock.
Mar 07
12:05pm ET
Why Viking Therapeutics Stock Is Plunging Today
Mar 06
5:50am ET
Is Viking Therapeutics Stock a Better Buy Than Eli Lilly and Novo Nordisk After the Latest Weight-Loss Drug News?
Mar 05
11:16am ET
A New Competitor to Wegovy Could Be on the Way. Should Novo Nordisk Be Worried?
Mar 05
6:15am ET
Better Weight Loss Drug Stock: Viking Therapeutics vs. Eli Lilly
No recent press releases are available for VKTX
VKTX Financials
Key terms
Ad Feedback
VKTX Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
VKTX Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range